A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria : a real-world study in Belgium
Background: Chronic spontaneous urticaria (CSU) is characterized by the repeated occurrence of persistent hives and/or angioedema for ≥6 weeks, without specific external stimuli. H1-antihistamines have long been the standard of care of CSU, but many patients remain uncontrolled even at 4× the approved dose. Add-on therapy with omalizumab has proven effective in clinical trials, but little is known about omalizumab treatment in Belgium. Objective: To collect real-world clinical data on omalizumab treatment in adults with CSU in Belgium. Methods: This was an observational, retrospective chart re... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journalarticle |
Erscheinungsdatum: | 2020 |
Schlagwörter: | Medicine and Health Sciences / Infectious Diseases / Dermatology / CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA / CHRONIC IDIOPATHIC URTICARIA / QUALITY INDEX DLQI / LIFE / MANAGEMENT / GUIDELINE / VALIDATION / ANGIOEDEMA / EXPERIENCE / INTERVALS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28959262 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://biblio.ugent.be/publication/8714235 |